Skip to main content

New medications for treatment-resistant depression: a brief review of recent developments.

Author
Abstract
:

There is a great unmet need for new medications with novel mechanisms of action that can effectively treat patients who do not benefit from standard antidepressant therapies. After a period in which it seemed as if the pharmaceutical pipeline for new antidepressants was going dry, the past decade has witnessed renewed interest, beginning with discovery of the antidepressant effects of ketamine. This article briefly highlights more recent research on ketamine and other investigational antidepressants.

Year of Publication
:
2017
Journal
:
CNS spectrums
Volume
:
22
Issue
:
S1
Number of Pages
:
39-48
ISSN Number
:
1092-8529
URL
:
https://www.cambridge.org/core/product/identifier/S1092852917000876/type/journal_article
DOI
:
10.1017/S1092852917000876
Short Title
:
CNS Spectr
Download citation